Cellectar Biosciences (CLRB) Stock Price, Quote, News & History | Benzinga

Cellectar Biosciences Inc (CLRB) Stock Price, Quote, News & History

CLRBNASDAQ

Trade with Public

Trade with Public

$2.54

N/A

At close: Aug 25, 5:00 PM EST

$2.48

-0.057-2.24%

Pre-Market: 4:00 AM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Stock Report

Key Statistics

Open

-

Close

$2.54

Volume / Avg.

0 / 99.15K

Day Range

- - -

52 Wk Range

2.20 - 6.52

Market Cap

$23.47M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

43

Short Interest

1.71%

Days to Cover

5.39

Recent Cellectar Biosciences Inc News

What's Going With Cellectar Biosciences Stock On Wednesday?

Cellectar shares slip premarket after rally as CLOVER WaM data, financing plans, and technical signals shape outlook for CLRB stock.

Vandana Singh

Crude Oil Down 4%; PayPal Shares Fall After Q1 Results

US stocks rise, Nasdaq gains 1%. Dow up 0.57%, Nasdaq up 1.03%, S&P 500 up 0.84%. Materials up 2.1%, financials down 0.2%. PayPal shares fall 9%.

Avi Kapoor

Dow Jumps Over 300 Points; Pfizer Posts Upbeat Earnings

US stocks rise, Dow gains 300 points. Materials jump 1.8%, real estate falls 0.2%. Pfizer's Q1 earnings beat expectations. Asian markets close lower.

Avi Kapoor

Cellectar Biosciences Stock Rallies As Blood Cancer Data Impresses

Cellectar releases Phase 2b CLOVER WaM data showing strong response rates and durability, alongside $140 million financing.

Vandana Singh

Why Bark Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-19.47M

Investing Cash Flow (TTM)

-9.26K

Financing Cash Flow (TTM)

42.44M

Free Cash Flow (TTM)

-19.48M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

22.95M

Analyst Trends and Forecast

1

Mar

1

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

-$8.08M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

0.82

Earnings Yield % (TTM)

-85.66%

Earnings Yield % (FWD)

-118.99%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$3.16

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$33.99M

Debt to Equity

0.05

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

-

Close

$2.54

Volume / Avg.

0 / 99.15K

Day Range

- - -

52 Wk Range

2.20 - 6.52

Market Cap

$23.47M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

43

Short Interest

1.71%

Days to Cover

5.39

About

Sector

Health Care

Industry

Biotechnology

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid d...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Cellectar Biosciences (CLRB) stock?

A

You can purchase shares of Cellectar Biosciences (NASDAQ:CLRB) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Cellectar Biosciences (CLRB) competitors?

A

Other companies in Cellectar Biosciences’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Cellectar Biosciences (CLRB) stock?

A

Cellectar Biosciences has a consensus price target of $16.00.

Q

What is the current price for Cellectar Biosciences (CLRB)?

A

The stock price for Cellectar Biosciences (NASDAQ: CLRB) is $2.483 last updated August 26, 2026 at 8:47 AM EDT.

Q

Does Cellectar Biosciences (CLRB) pay a dividend?

A

There are no upcoming dividends for Cellectar Biosciences.

Q

When is Cellectar Biosciences (NASDAQ:CLRB) reporting earnings?

A

Cellectar Biosciences does not have any upcoming earnings scheduled.

Q

Is Cellectar Biosciences (CLRB) going to split?

A

There is no upcoming split for Cellectar Biosciences.

Q

What sector and industry does Cellectar Biosciences (CLRB) operate in?

A

Cellectar Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.